Skip to main content
TipRanks
Go Ultimate75% OFF

Mabpharm Limited (2181) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Mabpharm Limited has a market cap or net worth of HKD 2.02B. The enterprise value is HKD 2.00B.

Market Cap
HKD 2.02B
Enterprise Value
HKD 2.00B

Share Statistics

Mabpharm Limited has 4,124,080,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
4,124,080,000
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Mabpharm Limited’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 0.55%.

Return on Equity (ROE)
0.35
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
0.55%
Return on Capital Employed (ROCE)
0.01
Revenue Per Employee
1.60M
Profits Per Employee
141.25K
Employee Count
394
Asset Turnover
0.55
Inventory Turnover
0.79

Valuation Ratios

The current PE Ratio of Mabpharm Limited is 20.51. Mabpharm Limited’s PEG ratio is 0.04.

PE Ratio
20.51
PS Ratio
2.27
PB Ratio
8.95
Price to FCF
97.29
Price to Operating Cash Flow
17.42
PEG Ratio
0.04

Income Statement

In the last 12 months, Mabpharm Limited had revenue of 629.37M and earned 55.65M in profits. Earnings per share was 0.01.

Revenue
629.37M
Gross Profit
521.55M
Operating Income
4.68M
Pretax Income
4.05M
Net Income
55.65M
EBITDA
64.46M
Earnings Per Share (EPS)
0.01

Cash Flow

In the last 12 months, operating cash flow was 99.49M and capital expenditures -81.67M, giving a free cash flow of 17.82M billion.

Operating Cash Flow
99.49M
Free Cash Flow
17.82M
Free Cash Flow per Share
0.00

Dividends & Yields

Mabpharm Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
1.03%
Earnings Yield
4.89%

Stock Price Statistics

Beta
0.80
52-Week Price Change
-4.81%
50-Day Moving Average
0.46
200-Day Moving Average
0.45
Relative Strength Index (RSI)
57.47
Average Volume (3m)
59.81K

Important Dates

Mabpharm Limited upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 28, 2026
Next Earnings Date
Mar 31, 2027
Ex-Dividend Date
―

Financial Position

Mabpharm Limited as a current ratio of 0.81, with Debt / Equity ratio of 207.71%

Current Ratio
0.81
Quick Ratio
0.56
Debt to Market Cap
0.15
Net Debt to EBITDA
3.38
Interest Coverage Ratio
0.44

Taxes

In the past 12 months, Mabpharm Limited has paid -51.60M in taxes.

Income Tax
-51.60M
Effective Tax Rate
-12.73

Enterprise Valuation

Mabpharm Limited EV to EBITDA ratio is 20.18, with an EV/FCF ratio of 109.33.

EV to Sales
2.55
EV to EBITDA
20.18
EV to Free Cash Flow
109.33
EV to Operating Cash Flow
19.58

Balance Sheet

Mabpharm Limited has HKD 93.31M in cash and marketable securities with HKD 307.88M in debt, giving a net cash position of -HKD 214.57M billion.

Cash & Marketable Securities
HKD 93.31M
Total Debt
HKD 307.88M
Net Cash
-HKD 214.57M
Net Cash Per Share
-HKD 0.05
Tangible Book Value Per Share
HKD 0.01

Margins

Gross margin is 85.42%, with operating margin of 4.79%, and net profit margin of 11.09%.

Gross Margin
85.42%
Operating Margin
4.79%
Pretax Margin
4.27%
Net Profit Margin
11.09%
EBITDA Margin
12.63%
EBIT Margin
4.79%

Analyst Forecast

The average price target for Mabpharm Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
88.38%
EPS Growth Forecast
―

Scores

Smart Score
8
AI Score
51